Compositions and methods for alleviating impaired mental function, memory loss and reducing recovery time in anaesthetized mammals

a technology of memory loss and recovery time, applied in the field of compositions and methods for alleviating impaired mental function, memory loss and reducing recovery time in anaesthetized mammals, can solve the problems of age-dependent decrease in anaesthesia requirements, achieve improved water maze performance of rats, increase intracellular calcium, and improve the effect of calcium level

Inactive Publication Date: 2001-06-26
CARLEN PETER LOUIS
View PDF4 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The dysfunction in calcium homeostasis in brain neurons is thought to be one of the contributing factors to cognitive dysfunction in senescent humans and animals Aged rats show impairment in their cognitive abilities and increased calcium level in the specific hippocampus and cortex regions of their brain. We have found that in vivo treatment with the cell permeant calcium buffer, bis (O-aminophenoxy)-ethane-N,N,N,N-tetraacetic acid--acetoxymethyl ester (BAPTA-AM) affected the spatial memory of rats. Aged (22 months old) Fisher 344 rats were trained in a hidden platform version of a water maze constituting a hippocampally dependent learning task. The results showed that: (a) adminstration of BAPTA-AM (5 mg/kg) before each training session significantly improved rats' performance in the water maze; b) the improvement was mostly visible within the first 4-5 days of 8 days training; (c) all rats showed comparable performance at the end of training, but the controls never achieved better scores than BAPTA rats; and (d) a retention test carried out 35 days after the last BAPTA-AM injection revealed long lasting tendency of positi

Problems solved by technology

Accordingly, the age-dependent decrease in anaesthetic requirement is probably due to incr

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compositions and methods for alleviating impaired mental function, memory loss and reducing recovery time in anaesthetized mammals
  • Compositions and methods for alleviating impaired mental function, memory loss and reducing recovery time in anaesthetized mammals
  • Compositions and methods for alleviating impaired mental function, memory loss and reducing recovery time in anaesthetized mammals

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

Experimental Methods Relating to Spatial Learning

Two pilot experiments preceded the main experiment of the study. The core of the methodology was common to all experiments and is described in detail in this section referring to the main experiment. Any procedural differences and / or additional details are given in the description of each pilot experiment. Subjects.

Fisher 344 male rats, 22 months old at the beginning of behavioural testing were used in the study. Seventeen animals were purchased from the National Institute of Aging, Maryland , U.S.A. They were pathogen-free at the arrival, and were kept individually in standard plastic rat cages with water and food ad libitum. The colony room was maintained on 12:12 LD photoperiod (7:00 AM, lights on), with the ambient temperature at 21.+-.1.degree. C. and relative humidity at 55%. All animals were kept for two weeks to acclimatize to the new conditions before the experiment commenced. One week before the experiment, all animals were ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Molar densityaaaaaaaaaa
Pharmaceutically acceptableaaaaaaaaaa
Selectivityaaaaaaaaaa
Login to view more

Abstract

Composition and methods of alleviating impaired mental function and memory loss in mammals and reducing the recovery time from anaesthesia in age mammals, comprising treating the mammal with a non-toxic, enhancing effective amount of a cell membrane permeant calcium buffer. The buffer is preferably a calcium ion chelating agent having a KD selected from the range 1x10-4 to 1x10-8 Molar and being essentially calcium ion-selective over other metal ions. A most preferred buffer is BAPTA-AM.

Description

This invention relates to methods of alleviating impaired mental function, memory loss and reducing recovery time in anaesthetized mammals using a cell membrane permeant calcium buffer, said calcium buffers per se, pharmaceutical compositions comprising said calcium buffers and methods for the preparation of said pharmaceutical compositions.Progressive learning and memory impairment occurs during the normal course of aging (1,2,3). A strong functional link has been established between the hippocampal region of the brain and learning and memory of spatial information (4,5,6). Also, age-related changes in neuroanatomical, neurochemical and neurophysiological parameters of this structure of the brain have been well documented and causally linked to the etiology of memory impairment (5,7,8). This age-dependent impairment of spatial learning is strongly correlated with a deficit in the maintenance of neuronal activity long-term potentiation (LTP) in the hippocampus (9). LTP, a form of sy...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/00A61K31/198A61K31/185A61K31/225A61K31/21A61K31/195A61K45/00A61K31/215A61P25/28A61P43/00
CPCA61K31/00A61K31/195A61K31/198A61K31/225Y10S514/836Y10S424/06A61P25/28A61P43/00
Inventor CARLEN, PETER LOUISJANUS, CHRISTOPHER GEORGEEL-BEHEIRY, HOSSAM
Owner CARLEN PETER LOUIS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products